Mental Health

According to SAMHSA’s 2023 National Survey on Drug Use and Health, among adults aged 18 or older in 2023, 22.8% (or 58.7 million people) had any mental illness (AMI) in the past year, 23.0% of adults aged 18 or older (or 59.2 million people) received mental health treatment in the past year, an increase of 3.4 million from 2022.

According to the National Council, patients often overstate their medication adherence and clinicians generally overestimate their own ability to identify and quantify medication non-adherence among their patients. To help prevent adherence misjudgment, the National Council recommends that medication adherence be periodically monitored by laboratory testing.

Mental health medication testing provides enhanced visibility into non-adherence and potential risk factors. Navis Clinical Laboratories® offers an extensive toxicology drug testing menu with over 180 metabolites and parent drugs, including more than 60 mental health testing options.

What are you missing?

An analysis of drug test results from mental health patients where medications were reported as prescribed revealed surprising insights:

65%

Demonstrated inconsistent results

38%

Tested negative for prescribed medications

19%

Tested positive for illicit drugs

32%

Tested positive for non-prescribed medications

Analysis of 17,720 samples from mental health patients where a medication was reported as prescribed with the test order; Jan 2018–Sept 2019

Mental Health Medication Adherence Testing

Extensive Mental Health Test Menu

Navis Clinical Laboratories offers an extensive drug testing menu with over 180 metabolites and parent drugs, with more than 60 mental health testing options.

INTEGRATED RESULTS MANAGEMENT REPORTS

Laboratory results management reports allow you to easily monitor your testing protocols, testing frequency and positivity trends to help you offer better care for your patients.

LEARN MORE ABOUT

Toxicology testing for Mental Health Adherence

Non-adherence to medication represents a major problem that limits the effectiveness of treatment and adds to the burden of illness and cost of health care.

Drug testing is an effective technology when the right test is selected for the right person at the right time.

Medication adherence should be periodically monitored by laboratory testing.

Results should be used to guide patient care, modify treatment plans and confirm clinical impressions.

Based on risk assessment, match provider interventions with medication regimens to patient’s individual needs.

Medication non-adherence accounts for 30-50% of treatment failures

Studies show that patients often overstate adherence because they fear disappointing their provider and that clinicians generally overestimate their own ability to identify and quantify non-adherence among their patients, highlighting the importance of objective and validated approaches to measurement, such as testing.

Non-adherence to antipsychotic medications averages 42%
Non-adherence to antidepressant medications averages 34%

Medication Matters: Causes and Solutions to Medication Non-Adherence National Council for Behavioral Health’s Medical Director Institute, September 2018